Bone Morphogenetic Protein 7, Recombinant, Mouse (BMP7, OP-1, Osteogenic Protein-1)
Catalog Number:
USB-B2553-32E
- Images (0)
| Article Name: | Bone Morphogenetic Protein 7, Recombinant, Mouse (BMP7, OP-1, Osteogenic Protein-1) |
| Biozol Catalog Number: | USB-B2553-32E |
| Supplier Catalog Number: | B2553-32E |
| Alternative Catalog Number: | USB-B2553-32E-10 |
| Manufacturer: | US Biological |
| Category: | Molekularbiologie |
| Application: | ELISA |
| Bone morphogenetic protein 7 (BMP7), also known as osteogenic protein 1 (OP1), is a widely expressed TGFbeta super family member with important functions during embryogenesis, in the adult, and in disease. Mouse BMP7 is synthesized with a 29aa signal sequence, a 262 aa propeptide, and a 139 aa growth fact or domain. The growth factor domain of mouse BMP7 shares 98% and 100% aa sequence identity with human and rat BMP7, respectively. The BMP7 propeptide is cleaved intracellularly but remains in association with the growth factor domain. BMP7 is subsequently secreted as a tetramer that consists of two propeptides and two disulfidelinked growth factor domains. Mature BMP7 can also form disulfidelinked heterodimers with BMP2 or BMP4, complexes that show increased potency and range of activity compared to BMP7 homodimers. The presence of the propeptides in the BMP7 tetramer does not diminish the bioactivity of the growth factor domains. Secreted BMP7 is immobilized in the extracellular matrix as a result of interactions between the propeptide and matrix fibrillin. BMP7 exerts its biological effects through the type 2 receptors Activin RIIA, Activin RIIB, and BMPRI I and the t ype 1 receptors Activin RIA, BMPRIA, and BMPRIB. BMP7 plays a role in a variety of organ systems. It promotes new bone formation and nephron development, inhibits the branching of prostate epithelium, and antagonizes epithelialmesenchymal transition (EMT). In pathological conditions, BMP7 inhibits tumor growth and metastasis, ameliorates fibrotic damage in nephritis and promotes neuroregeneration following brain ischemia. Recombinant protein corresponding to Ser292-His430 from mouse Bone Morphogenetic Protein 7 expressed in CHO cells (NP_031583). Structure: Disulfide-linked homodimer SDS-PAGE: 16-20kD under reducing conditions Activity: Measured by its ability to induce alkaline phosphatase production by ATDC5 mouse chondrogenic cells. The ED50 for this effect is typically 0.125 0.5ug/ml. Applications: Suitable for use in ELISA. Other applications not tested. Recommended Dilutions: Optimal dilutions to be determined by the researcher. Storage and Stability: Lyophilized and reconstituted products are stable for 6 months after receipt at -20C. Reconstitute with sterile 4mM HCl. Aliquot to avoid repeated freezing and thawing. Store at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. |
Product Guarantee and Expert Support
